Beyond immunosuppression: reconsidering indoleamine 2,3-dioxygenase as a pathogenic element of chronic inflammation

Immunotherapy. 2010 May;2(3):293-7. doi: 10.2217/imt.10.22.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Arthritis, Rheumatoid / enzymology
  • Arthritis, Rheumatoid / metabolism
  • Arthritis, Rheumatoid / pathology
  • Autoimmunity / immunology
  • Chronic Disease
  • Humans
  • Indoleamine-Pyrrole 2,3,-Dioxygenase / immunology
  • Indoleamine-Pyrrole 2,3,-Dioxygenase / metabolism*
  • Inflammation / enzymology*
  • Inflammation / metabolism
  • Inflammation / pathology
  • Lupus Erythematosus, Systemic / enzymology
  • Lupus Erythematosus, Systemic / metabolism
  • Lupus Erythematosus, Systemic / pathology
  • Tryptophan / metabolism

Substances

  • Indoleamine-Pyrrole 2,3,-Dioxygenase
  • Tryptophan